Education
About Us
Working with TipRanks
Follow Us
Compass Therapeutics (CMPX)
NASDAQ:CMPX
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 850.00K | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 850.00K | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -56.63M | $ -50.36M | $ -41.66M | $ -81.88M | $ -27.81M |
| EBITDA | $ -54.87M | $ -48.47M | $ -39.75M | $ -80.19M | $ -25.41M |
| Net Income | $ -49.38M | $ -42.49M | $ -39.23M | $ -82.18M | $ -29.50M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 126.72M | $ 152.46M | $ 186.61M | $ 144.51M | $ 47.08M |
| Total Assets | $ 140.40M | $ 156.88M | $ 199.65M | $ 153.76M | $ 51.91M |
| Total Debt | $ 6.63M | $ 1.73M | $ 2.94M | $ 4.04M | $ 9.33M |
| Net Debt | $ -36.85M | $ -22.50M | $ -32.01M | $ -140.48M | $ -37.74M |
| Total Liabilities | $ 15.17M | $ 8.34M | $ 18.01M | $ 13.68M | $ 11.97M |
| Stockholders' Equity | $ 125.23M | $ 148.54M | $ 181.64M | $ 140.08M | $ 39.95M |
| Cash Flow | |||||
| Free Cash Flow | $ -44.90M | $ -40.65M | $ -34.34M | $ -21.23M | $ -26.91M |
| Operating Cash Flow | $ -44.85M | $ -40.62M | $ -34.13M | $ -19.67M | $ -26.80M |
| Investing Cash Flow | $ 46.77M | $ 26.96M | $ -151.20M | $ -1.77M | $ 38.00K |
| Financing Cash Flow | $ 17.34M | $ 2.94M | $ 75.76M | $ 118.61M | $ 48.54M |